Dengue “homegrown” in Europe (2022 to 2023)

J. C. Brem(University of Zurich), Patricia Schlagenhauf(World Health Organization - Pakistan), Bavatharani Elankeswaran(University of Zurich), Thibault Lovey(University of Zurich), Viviana Marzetta(University of Zurich), Laura Tarrago Salvado(University of Zurich), Céline Züger(University of Zurich), David Erne(University of Zurich), Nadja Hedrich(University of Zurich)
New Microbes and New Infections
November 23, 2023
10.1016/j.nmni.2023.101205
Cited by 48

Related Papers

Covid-19 and community mitigation strategies in a pandemic
|BMJ|2020|584
Going global – Travel and the 2019 novel coronavirus
|Travel Medicine and Infectious Disease|2020|376
Chikungunya and dengue autochthonous cases in Europe, 2007–2012
|Travel Medicine and Infectious Disease|2013|255
Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation
|The Lancet Infectious Diseases|2014|248
Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study
|BMJ|2003|243